| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $12.1M | +2.5% |
| Cost of Revenue | $14.8M | +42.6% |
| Gross Profit | -$2.6M | -277.6% |
| R&D Expense | $12.3M | -2.7% |
| SG&A Expense | $18.6M | -11.6% |
| Operating Income | -$52.3M | -23.8% |
| Pre-tax Income | -$50.1M | -23.0% |
| Net Income | -$50.1M | -23.0% |
| EPS (Basic) | -$0.79 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $26.6M | -63.4% |
| Accounts Receivable | $3.8M | +7.6% |
| Inventory | $9.0M | -20.1% |
| Current Assets | $41.5M | -54.5% |
| Total Assets | $86.1M | -34.9% |
| Current Liabilities | $5.2M | -65.9% |
| Total Liabilities | $5.4M | -65.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$26.3M | -7.2% |
| Capital Expenditures | $5.3M | +208.9% |
| Investing Cash Flow | -$19.3M | +8.9% |
| Financing Cash Flow | -$450K | +76.9% |
| Free Cash Flow | -$31.6M | -20.4% |
| -23.4% |
| EPS (Diluted) | -$0.79 | -23.4% |
| Stockholders' Equity |
| $80.8M |
| -30.8% |